Skip to main content

Table 1 Detail parameters of both groups.

From: Comparative study of sequential intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma- a randomized trial

Parameters Group A Group B P value
  (MMC+Gemcitabine) (MMC)  
Total patients 102 96 NS+
Male 81 78 NS+
Female 21 19 NS+
Age 65.7±9.8 yrs 63.9±8.9 yrs NS+
Mean Duration of follow up 36 months 36 months  
Mean size of tumor <2cm 63 58 NS+
Mean sixe of tume >2 cm 39 38 NS+
Stage Ta 60 58 NS+
Stage T1 42 38 NS+
Grade 1 19 17 NS+
Grade 2 63 61 NS+
Grade 3 20 18 NS+
Previous treatment with BCG All All  
Aim of complete response 100% 100%  
Actual complete response 83.67% (82) 65.6% (63) 0.001*
Recurrence % 12.2% (12) 25.3% (16) 0.001*
Recurrence 22±6.16 months 14.5±8.26 months 0.001*
Recurrence range in months 8-36 months 4-14 months  
  1. Values are presented as mean (+/- standard devitation)
  2. Group A: Gemcitabine & Mitomycin (MMC+Gentamycin)
  3. Group B: Mitomycin C(MMS)
  4. *Statistical significance was analyzed by student t-test
  5. +Statistical significance was analyzed by the chi-square test.